Imperial Innovations Group Share News (IVO)

Imperial Innovations Increases Investment In TopiVert To GBP8.5 Million

Imperial Innovations' Portfolio Firm Oxford Immunotec Starts Trading On NASDAQ

Imperial Innovations Invests In Inhaled Medicines Company Pulmocide

Imperial Innovations Take Part In Mission Therapeutics Funding Round

Thursday tips round-up: Imperial Innovations, Vertu Motors

Imperial Innovations has the right to take interesting discoveries from Imperial College London and package them up into companies that eventually can be floated or sold. The majority of its 92 investments are in pharmaceuticals; one of the most promising, Circassia, is well into clinical trials for

Imperial Innovations portfolio value rises as companies near IPO

Imperial Innovations accompanied news of a full year rise in its portfolio value with the announcement of a Nasdaq flotation for portfolio company Oxford Immunotec. The university spin-out group said had "a number" of companies in its portfolio also ready for initial public offering (IPO) or trade

Imperial Innovations Profts Drop But Portfolio Value Rises

Imperial Innovations Makes New Investment As Old One Gets Good Results

Imperial Innovations Says Circassia's Dust-Mite Study Successful

Innovations CEO steps down

Technology commercialisation and investment group Imperial Innovations confirmed that Chief Executive Susan Searle has stepped down after 11 years in the role. Chief investment officer Russ Cummings, who has been a director since the group's flotation in 2006, has taken over as CEO with immediate

Kelsey Lynn appointed Director of Technology Ventures at Imperial Innovations Group

AIM-listed technology commercialisation and investment group Imperial Innovations Group has reported that that Kelsey Lynn has joined as Director of Technology Ventures with immediate effect. Lynn spent the last twelve years in California, working in new technology development and venture capital

Imperial Innovations reports strong progress in top three portfolio companies

Imperial Innovations, a technology commercialisation and investment group, on Friday reported 'really good' progress in its top three portfolio companies in its half year results. The firm said that in the six months ended January 31st its top three portfolio companies, namely Circassia, Nexeon an

Imperial Innovations reports that Nexeon signed partnership with WACKER

AIM-listed technology commercialisation and investment group Imperial Innovations has announced that portfolio company Nexeon, a battery materials and licensing company, has signed a strategic partnership agreement with German chemical company WACKER Chemie AG (WACKER). The group reported that WAC

Imperial Innovations invests 1.5m pounds in tech firm Semetric

Technology commercialisation and investment group Imperial Innovations has invested 1.5m pounds in technology firm Semetric, the company behind global music analytics specialist, Musicmetric. The group said that the investment was part of a £3m funding round which also included its existing investo

Imperial Innovations rises to university challenge

A change in the fair value of investments held by Imperial Innovations, the hot-house for technology and healthcare ideas from Britain's universities, saw full year profits surge. Revenues eased, however, reflecting the continuing difficult economic environment. Total revenues in the year to the en